The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia.

Joni Van der Meulen,Viraj Sanghvi, Konstantinos Mavrakis,Kaat Durinck,Fang Fang, Filip Matthijssens,Pieter Rondou, Monica Rosen,Tim Pieters, Peter Vandenberghe,Eric Delabesse, Tim Lammens,Barbara De Moerloose, Björn Menten,Nadine Van Roy, Bruno Verhasselt,Bruce Poppe, Yves Benoit,Tom Taghon,Ari M Melnick, Frank Speleman,Hans-Guido Wendel,Pieter Van Vlierberghe

Blood(2014)

引用 159|浏览36
暂无评分
摘要
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form of leukemia that is mainly diagnosed in children and shows a skewed gender distribution toward males. In this study, we report somatic loss-of-function mutations in the X-linked histone H3K27me3 demethylase ubiquitously transcribed X (UTX) chromosome, in human T-ALL. Interestingly, UTX mutations were exclusively present in male T-ALL patients and allelic expression analysis revealed that UTX escapes X-inactivation in female T-ALL lymphoblasts and normal T cells. Notably, we demonstrate in vitro and in vivo that the H3K27me3 demethylase UTX functions as a bona fide tumor suppressor in T-ALL. Moreover, T-ALL driven by UTX inactivation exhibits collateral sensitivity to pharmacologic H3K27me3 inhibition. All together, our results show how a gender-specific and therapeutically relevant defect in balancing H3K27 methylation contributes to T-cell leukemogenesis.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要